by angelliu | Jun 4, 2018 | News
Source: Japan’s Takeda Pharmaceutical is about to become a major international player on the biopharma scene, with its purchase of larger Irish rival Shire (SHPG, +1.41%). It’s one of the biggest pharma deals in history, and the largest-ever international...
by qfrsolutions | May 1, 2018 | News
Source: Business Wire MALVERN, Pa.–(BUSINESS WIRE)–Encore Dermatology Inc. announces today the availability of a new topical product, IMPOYZ Cream, indicated for the treatment of moderate to severe plaque psoriasis in patients 18 years of age or older....
by qfrsolutions | Apr 30, 2018 | News
Source: PR Newswire SAN FRANCISCO, April 30, 2018 /PRNewswire/ — Datavant, the leader in helping healthcare organizations safely link their data to improve medical research and patient care, today announced that it has acquired Universal Patient Key (UPK), the...
by qfrsolutions | Mar 22, 2018 | News
Source: “Sun Pharma” and includes its subsidiaries and/or associate companies) announced that the U.S. Food and Drug Administration (FDA) has approved ILUMYA™ (tildrakizumab-asmn) for the treatment of adults with moderate-to-severe plaque psoriasis...
by qfrsolutions | Mar 8, 2018 | News
Source: Drives greater affordability and connectivity with customers and their health care providers, while making health care simpler Creates an expanded portfolio of health services with greater choice, alignment and value across a proven services platform Expands...
by qfrsolutions | Feb 14, 2018 | News
Source: WESTLAKE VILLAGE, Calif., Feb. 14, 2018 (GLOBE NEWSWIRE) — Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA) today announced that the first patient has been dosed in the Company’s first-in-human, Phase 1/2 proof-of-concept clinical trial of topical...
